Europe Automated Intravenous Oncology Compounding Devices Market Size By Product Type (Macro Devices, Micro Devices, Major/Micro Devices), By Technology (Gravimetric Devices, Volumetric Devices), By End-Use (Hospitals, Chemotherapy Centers), By Geographic Scope And Forecast
Report ID: 74830|No. of Pages: 202
Europe Automated Intravenous Oncology Compounding Devices Market Size By Product Type (Macro Devices, Micro Devices, Major/Micro Devices), By Technology (Gravimetric Devices, Volumetric Devices), By End-Use (Hospitals, Chemotherapy Centers), By Geographic Scope And Forecast
Europe Automated Intravenous Oncology Compounding Devices Market Size And Forecast
Europe Automated Intravenous Oncology Compounding Devices Market size was valued at USD 761.3 Million in 2024 and is projected to reach USD 1,246.6 Million by 2031 growing at a CAGR of 7.10% from 2024 to 2031.
A fully automated compounding system mixes one or more medication solutions into a final container for patient administration. The Automated Intravenous Oncology Compounding Devices Market is increasing in Europe, owing to increased acceptance of chemotherapy and customized medication, as well as a growing demand to reduce drug errors. The Europe Automated Intravenous Oncology Compounding Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Europe Automated Intravenous Oncology Compounding Devices Market Definition
Automated Compounding Devices (Oncology) are devices that assist in the aseptic transfer of one or more sterile component solutions to a sterile final container for patient preparation, reducing the need for syringes. The devices are known for providing superior ingredient distribution precision, as well as lowering preparation time and limiting patient injuries. This helps prevent prescription mistakes caused by a range of variables including inadequate management communication between the physician and pharmacist, important pharmacy storage procedures, and confusion caused by the usage of identical labels.
Automated compounding technologies, on the other hand, have enhanced the precision and efficiency of administering compounded pharmaceuticals while also reducing the exposure of healthcare practitioners to harmful substances. The gravimetric method and the volumetric methods are the two basic approaches employed in ACD technology. Furthermore, the chemotherapeutic medicines involved are sometimes very toxic, with a poor therapeutic index, necessitating the use of high-precision drug preparation.
The precision of these ACDs is related to the volume that must be transmitted, implying that the bigger the volume, the higher the device’s accuracy. As a result, manufacturers provide a variety of transferable volumes to meet the demands of a wide spectrum of clients. The gadgets are used to measure powdered and liquid components in both hospitals and pharmacies.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=74830
Europe Automated Intravenous Oncology Compounding Devices Market Overview
Europe Automated Intravenous Oncology Compounding Devices Market is expected to increase due to the rising adoption of chemotherapy and customized medicine, better efficiency & accuracy of the device, reduced exposure to cytotoxic material, and a reduced risk of contamination. Furthermore, the market is driven by the decrease in hospital per-dose costs and the removal of contamination that is necessary when compounding solutions.
The increased need to reduce medical mistakes is also a driving force for the growth. Additionally, during the projected period, the adoption of new robotic technology automation in compounding systems is expected to boost the market growth. However, the high installation cost of devices, reluctance to accept devices, and lacked skilled resources are major restraints to the market’s growth.
Europe Automated Intravenous Oncology Compounding Devices Market: Segmentation Analysis
The Europe Automated Intravenous Oncology Compounding Devices Market is Segmented on the basis of Product Type, Technology, End-Use, And Geography.
Europe Automated Intravenous Oncology Compounding Devices Market, By Product Type
• Macro Devices
• Micro Devices
• Major/Micro Devices
Based on Product Type, The market is segmented into Macro Devices, Micro Devices, Major/Micro Devices. Macro devices are used in hospitals for radiation purposes, thus they are projected to dominate the market.
Europe Automated Intravenous Oncology Compounding Devices Market, By Technology
• Gravimetric Devices
• Volumetric Devices
Based on Technology, The market is segmented into Gravimetric Devices and Volumetric Devices. In the treatment of cancer, gravimetric analysis employs quartz crystal microbalance (QCM) transducers and synthetic receptors, which is predicted to boost the market.
Europe Automated Intravenous Oncology Compounding Devices Market, By End-Use
• Hospitals
• Chemotherapy Centers
Based on End-Use, The market is segmented into Hospitals and Chemotherapy Centers. Hospitals are expected to rise the most during the forecasted period due to an increased number of patients with Cancer, reduced medication errors, and cost-effectiveness.
Europe Automated Intravenous Oncology Compounding Devices Market, By Geography
• Germany
• U.K.
• France
• Rest of Europe
On the basis of Geography, The Europe Automated Intravenous Oncology Compounding Devices Market is classified into Germany, U.K., France, and the Rest of Europe.
Key Players
The “ Europe Automated Intravenous Oncology Compounding Devices Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Comecer, Locioni, ICU Medical, Baxter Healthcare Corporation, SA Equashield, B. Braun Medical Inc., Omnicell Inc, Arxium, Grifols International, and Weibond Technologies.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
• In 2019, Fagron & JCB Laboratories opened one of the largest 503B human drug outsourcing facilities.
• In December 2018, Arxium introduced its cGMP RIVA IV, a fully automated compounding system for hospitals.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| HISTORICAL PERIOD | 2021-2023 |
| Key Companies Profiled | Comecer, Locioni, ICU Medical, Baxter Healthcare Corporation, SA Equashield, B. Braun Medical Inc., Omnicell Inc, Arxium, Grifols International, and Weibond Technologies. |
| Segments Covered | By Product Type, By Technology, By End-Use, And By Geography. |
| Customization scope | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements, please connect with our sales team to ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF EUROPE AUTOMATED INTRAVENOUS ONCOLOGY COMPOUNDING DEVICES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 EUROPE AUTOMATED INTRAVENOUS ONCOLOGY COMPOUNDING DEVICES MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 EUROPE AUTOMATED INTRAVENOUS ONCOLOGY COMPOUNDING DEVICES MARKET, BY PRODUCT TYPE
5.1 Overview
5.2 Macro Devices
5.3 Micro Devices
5.4 Macro/Micro Devices
6 EUROPE AUTOMATED INTRAVENOUS ONCOLOGY COMPOUNDING DEVICES MARKET, BY TECHNOLOGY
6.1 Overview
6.2 Gravimetric Devices
6.3 Volumetric Devices
7 EUROPE AUTOMATED INTRAVENOUS ONCOLOGY COMPOUNDING DEVICES MARKET, BY END-USE
7.1 Overview
7.2 Hospitals
7.3 Chemotherapy Centers
8. EUROPE AUTOMATED INTRAVENOUS ONCOLOGY COMPOUNDING DEVICES MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Germany
8.3. U.K.
8.4. France
8.5. Rest of Europe
9 EUROPE AUTOMATED INTRAVENOUS ONCOLOGY COMPOUNDING DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 COMPANY PROFILES
10.1 Comecer
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Locioni
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 ICU Medical
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Baxter Healthcare Corporation
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 SA Equashield
10.5.1 Overview
10.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
10.6 B. Braun Medical Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Omnicell Inc
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Arxium
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Grifols International
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Weibond Technologies
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 KEY DEVELOPMENTS
11.1 Product Launches/Developments
11.2 Mergers and Acquisitions
11.3 Business Expansions
11.4 Partnerships and Collaborations
12 Appendix
12.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
Europe Automated Intravenous Oncology Compounding Devices Market
Download Sample Report